E3 PreliminaryWeak / uncertainPEM unclearReview-NarrativePeer-reviewedMachine draft
Fungal spores: hazardous to health?
Sorenson, W G · Environmental health perspectives · 1999 · DOI
Quick Summary
This review discusses how fungal spores in the air can affect human health. Fungal spores are tiny particles that can enter the lungs when inhaled, and some contain harmful substances called mycotoxins. The article notes that breathing in fungal spores has been linked to various health problems, including chronic fatigue syndrome, along with lung disease and other serious conditions.
Why It Matters
This work is significant because it specifically identifies chronic fatigue syndrome as a potential health outcome associated with fungal spore inhalation, linking environmental exposure to ME/CFS pathophysiology. For ME/CFS researchers and patients, this suggests an environmental exposure pathway that warrants investigation as a potential trigger or contributing factor to disease.
Observed Findings
- Fungal spores with aerodynamic diameter less than 5 micrometers can enter human lungs
- Fungal spores may contain significant amounts of mycotoxins
- Inhalation of fungal spores has been associated with multiple disease states including toxic pneumonitis, hypersensitivity pneumonitis, tremors, chronic fatigue syndrome, kidney failure, and cancer
Inferred Conclusions
- Fungal spores represent an underrecognized environmental health hazard to humans
- Inhalation exposure to fungal spores may be a contributing factor in chronic fatigue syndrome and other systemic conditions
- The mycotoxin content of fungal spores may mediate pathogenic effects of spore inhalation
Remaining Questions
- What is the prevalence of elevated fungal spore exposure in ME/CFS patient populations compared to healthy controls?
- What are the specific mechanisms by which fungal spore inhalation or mycotoxin exposure might trigger or perpetuate ME/CFS pathophysiology?
- Which fungal species and their spores are most relevant to ME/CFS, and how can exposure be measured and quantified in patients?
- What clinical interventions or exposure reduction strategies might benefit ME/CFS patients with fungal exposure as a potential contributing factor?
What This Study Does Not Prove
This review does not prove that fungal spores cause ME/CFS, nor does it establish the prevalence of fungal exposure in ME/CFS populations or demonstrate causality rather than association. The article lists chronic fatigue syndrome among multiple diverse outcomes without providing epidemiological evidence, mechanistic studies, or clinical data specific to ME/CFS.
Tags
Symptom:Fatigue
Method Flag:Exploratory Only
Metadata
- DOI
- 10.1289/ehp.99107s3469
- PMID
- 10423389
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →